rewirebio.iobenchmarks
← Back to results
Result

100% sensitivity

STAR-Fusion sensitivity

Tested configuration
STAR-Fusion
Protocol
EnFusion undiluted Seraseq duplicate benchmark
Dataset
Undiluted Seraseq Fusion RNA control, duplicate libraries
Procedure
Consensus ≥3 callers, with specified filtering and known fusion list rescue; Table 2 displays mean of duplicate undiluted experiments. Only 14 Seraseq fusions are positive; all others counted false positive. Comparators processed by same authors.
Evaluation
STAR-Fusion evaluation
Coverage
scored: unreported; eligible: unreported
Uncertainty
Not reported
Evidence
Independent external evaluation · source checkedDiscovery of clinically relevant fusions in pediatric cancer · Table 2, STAR-Fusion row, corresponding column (JATS Tab2)

A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.

Reproduction

Split
optimization/reference control
Adaptation
Not reported
Scoring implementation
Not reported

No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.

Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

1 evidence row matching the loaded filters

Claims, original sources and review scope · Release 2026-10-07-1448159e6a81
Property and statementOriginal source and locationReview and provenance
Reported result
100.0%
Individual claims		Discovery of clinically relevant fusions in pediatric cancer

Original source ↗

Table 2, STAR-Fusion row, corresponding column (JATS Tab2)

Version: Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00
Retrieved: 2026-10-07T12:25:20.810843+00:00

source checked

automated source review · 2026-10-07T13:38:59Z

independent paper

Audit details

Bounded transcription of a Codex-checked primary-source cell. No independent experimental reproduction or qualified human scientific review.

Field: attributes.printed_value

Source artifact SHA-256: a5fd574d3b186fa29f835aff44491e1d1d0447ea2352f627c21f95ca666e9225

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

All evidence (CSV)All evidence (JSONL)How to read the evidence

Sources and history

View linked audit checks and correction history

Release 2026-10-07-1448159e6a81 · Record review: source checked

1 source records and release historyDownload this release
Technical metadata and extraction receipts

Stable ID: amp-oncology-rna-20261007-issue-11-result-star-fusion-sensitivity

metric
sensitivity
metric direction
higher
missing metadata
None recorded
numeric value
100.0
printed value
100.0%
review
method: automated_source_review; notes: Bounded transcription of a Codex-checked primary-source cell. No independent experimental reproduction or qualified human scientific review.; reviewed at: 2026-10-07T13:38:59Z; reviewer: Claude Sonnet AMP-integration worker, bounded transcription of Codex-checked primary values (workbench/amp-supervision/primary-review.md, integration-review-corrections.md); pending qualified human scientific review
source locator
Table 2, STAR-Fusion row, corresponding column (JATS Tab2)
uncertainty
Not reported
unit
%
Related records

Suggest a correction